Outset Medical, Inc. (NASDAQ:OM - Get Free Report) has been assigned an average recommendation of "Hold" from the five ratings firms that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued a report on the stock in the last year is $10.00.
A number of research firms have recently commented on OM. Weiss Ratings restated a "sell (e+)" rating on shares of Outset Medical in a research note on Wednesday. Wall Street Zen raised Outset Medical from a "sell" rating to a "hold" rating in a research report on Saturday, August 15th.
Check Out Our Latest Stock Analysis on Outset Medical
Outset Medical Stock Down 3.4%
Outset Medical stock opened at $2.81 on Friday. Outset Medical has a one year low of $2.77 and a one year high of $6.49. The company has a debt-to-equity ratio of 1.19, a quick ratio of 3.85 and a current ratio of 4.86. The firm has a market capitalization of $53.02 million, a P/E ratio of -0.73 and a beta of 1.93. The company has a 50-day simple moving average of $3.72 and a 200-day simple moving average of $4.05.
Outset Medical (NASDAQ:OM - Get Free Report) last released its earnings results on Wednesday, November 4th. The company reported ($0.68) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.69) by $0.01. Outset Medical had a negative return on equity of 66.98% and a negative net margin of 58.33%. The company had revenue of $33.60 million during the quarter, compared to analyst estimates of $31.40 million. As a group, equities analysts expect that Outset Medical will post -3.51 earnings per share for the current year.
Hedge Funds Weigh In On Outset Medical
Several hedge funds and other institutional investors have recently modified their holdings of the company. Algert Global LLC purchased a new stake in shares of Outset Medical in the 3rd quarter worth approximately $58,000. Squarepoint Ops LLC purchased a new position in Outset Medical in the 2nd quarter worth about $98,000. Empowered Funds LLC purchased a new stake in Outset Medical during the third quarter worth $74,000. Bank of New York Mellon Corp purchased a new stake in shares of Outset Medical during the second quarter worth about $121,000. Finally, Sei Investments Co. increased its stake in shares of Outset Medical by 15.5% in the first quarter. Sei Investments Co. now owns 35,366 shares of the company's stock worth $136,000 after acquiring an additional 4,738 shares during the period.
About Outset Medical
(
Get Free Report)
Outset Medical is a medical technology company that develops and sells products for hemodialysis, a treatment that filters waste and excess fluid from the blood. Its main product is the Tablo Hemodialysis System, an integrated dialysis platform designed for use in hospitals, clinics and home settings. Tablo combines dialysis equipment with water purification and a touchscreen interface, aiming to simplify treatment setup and operation. The system also supports access to treatment data through connected software tools.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Outset Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Outset Medical wasn't on the list.
While Outset Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.